Last 7 days
-4.7%
Last 30 days
-6.8%
Last 90 days
-14.1%
Trailing 12 Months
-20.2%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-09-15 | Hoge Stephen | sold | -1,694,850 | 112 | -15,000 | president |
2023-09-15 | Bancel Stephane | acquired | - | - | 17,893 | chief executive officer |
2023-09-13 | AFEYAN NOUBAR | sold | -1,645,520 | 109 | -15,000 | - |
2023-09-08 | Klinger Shannon Thyme | sold | -59,722 | 107 | -557 | chief legal officer |
2023-09-07 | Klinger Shannon Thyme | acquired | - | - | 1,138 | chief legal officer |
2023-09-06 | Garay Arpa | sold | -62,219 | 108 | -574 | chief commercial officer |
2023-09-06 | AFEYAN NOUBAR | sold | -1,614,090 | 107 | -15,000 | - |
2023-09-05 | Klinger Shannon Thyme | sold | -12,815 | 111 | -115 | chief legal officer |
2023-09-05 | Hoge Stephen | sold | -35,659 | 111 | -320 | president |
2023-09-05 | Garay Arpa | acquired | - | - | 1,140 | chief commercial officer |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-09-14 | IMS Capital Management | sold off | -100 | -1,203,150 | - | -% |
2023-09-12 | Farther Finance Advisors, LLC | added | 22.81 | -498 | 17,010 | -% |
2023-09-07 | Triatomic Management LP | added | 19.32 | -37,877 | 637,875 | 0.65% |
2023-09-05 | Delos Wealth Advisors, LLC | unchanged | - | -32.00 | 122 | -% |
2023-09-01 | Manhattan West Asset Management, LLC | added | 116 | 607,201 | 1,454,960 | 0.54% |
2023-08-24 | Alberta Investment Management Corp | unchanged | - | -2,817,430 | 10,670,700 | 0.10% |
2023-08-23 | Stonebridge Capital Advisors LLC | unchanged | - | -7,859 | 29,768 | -% |
2023-08-23 | WOLVERINE TRADING, LLC | added | 635 | 2,608,890 | 3,120,890 | -% |
2023-08-22 | Asset Dedication, LLC | unchanged | - | -23,000 | 87,000 | 0.01% |
2023-08-22 | COMERICA BANK | new | - | 29,000 | 29,000 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 09, 2023 | vanguard group inc | 7.10% | 27,282,173 | SC 13G/A | |
Feb 01, 2023 | blackrock inc. | 6.8% | 26,115,224 | SC 13G/A | |
Jan 19, 2023 | baillie gifford & co | 11.66% | 44,786,746 | SC 13G/A | |
Feb 14, 2022 | bancel stephane | 7.64% | 31,538,184 | SC 13G/A | |
Feb 14, 2022 | flagship ventures fund iv general partner llc | 2.8% | 11,460,435 | SC 13G/A | |
Feb 04, 2022 | blackrock inc. | 6.8% | 27,661,473 | SC 13G | |
Jan 26, 2022 | baillie gifford & co | 11.29% | 45,772,079 | SC 13G/A | |
Jul 12, 2021 | blackrock inc. | 4.8% | 19,390,725 | SC 13G/A | |
Mar 01, 2021 | baillie gifford & co | 11.18% | 44,691,386 | SC 13G/A | |
Feb 16, 2021 | flagship ventures fund iv general partner llc | 2.9% | 11,460,435 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Sep 20, 2023 | 144 | Notice of Insider Sale Intent | |
Sep 18, 2023 | 4 | Insider Trading | |
Sep 15, 2023 | 144 | Notice of Insider Sale Intent | |
Sep 15, 2023 | 4 | Insider Trading | |
Sep 15, 2023 | 4 | Insider Trading | |
Sep 13, 2023 | 144 | Notice of Insider Sale Intent | |
Sep 11, 2023 | 4 | Insider Trading | |
Sep 11, 2023 | 8-K | Current Report | |
Sep 08, 2023 | 144 | Notice of Insider Sale Intent | |
Sep 08, 2023 | 4 | Insider Trading |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
AMGN | 145.2B | 26.6B | 4.13% | 21.09% | 18.2 | 5.46 | 0.75% | 21.34% |
GILD | 94.5B | 27.4B | -0.16% | 19.51% | 17.24 | 3.45 | -0.48% | 32.56% |
MRNA | 39.4B | 10.7B | -6.80% | -20.18% | 32.68 | 3.7 | -53.67% | -91.41% |
BIIB | 37.7B | 10.0B | -1.71% | 27.59% | 14.15 | 3.78 | -6.23% | 29.40% |
MID-CAP | ||||||||
NBIX | 11.2B | 1.7B | 5.59% | 6.81% | 63.29 | 6.67 | 29.01% | 1345.90% |
BBIO | 4.5B | - | -3.04% | 140.92% | -7.66 | 48.33 | 54.84% | -12.96% |
DNLI | 3.1B | - | -4.51% | -22.98% | -23.78 | 37.44 | 122.90% | 54.78% |
BEAM | 2.0B | 80.2M | 6.46% | -52.82% | -6.01 | 24.54 | 42.17% | -39.82% |
SMALL-CAP | ||||||||
RCUS | 1.5B | 121.2M | 4.38% | -25.42% | -5.13 | 12.17 | -70.36% | -531.73% |
REPL | 980.2M | 15.3M | -15.63% | 3.04% | -5.4 | 64.02 | 1090.59% | -36.57% |
NVAX | 664.9M | 1.6B | -12.64% | -74.33% | -1.13 | 0.42 | 23.74% | 60.24% |
FATE | 221.7M | - | -17.58% | -90.72% | -1.05 | 1.62 | 116.83% | 16.61% |
SGMO | 146.7M | - | -8.84% | -84.12% | -0.74 | 0.61 | 113.96% | -15.19% |
VXRT | 112.7M | 2.1M | -6.14% | -67.90% | -1.12 | 54.83 | 487.70% | -8.66% |
IBIO | 4.1M | - | -12.28% | -96.10% | -0.05 | 3.21 | - | -129.46% |
14.0%
99.2%
83.4%
49.4%
Y-axis is the maximum loss one would have experienced if Moderna was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Revenue | -29.3% | 10,654,000,000 | 15,059,000,000 | 19,263,000,000 | 21,390,000,000 | 22,995,000,000 | 22,600,000,000 | 18,471,000,000 | 11,831,000,000 | 7,019,000,000 | 2,732,000,000 | 803,000,000 | 246,055,000 | 106,101,000 | 52,184,000 | 60,209,000 | 81,575,000 | 106,286,000 | 122,054,000 | 135,068,000 | 191,551,000 | 192,266,000 |
Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | 865,367,000 | 620,150,000 | 588,464,000 | 606,879,000 | 650,720,000 | 630,485,000 | 599,559,000 | 548,334,000 | 493,614,000 | 476,382,000 |
S&GA Expenses | 10.4% | 1,290,000,000 | 1,169,000,000 | 1,132,000,000 | 958,000,000 | 848,000,000 | 758,000,000 | 567,000,000 | 445,000,000 | 325,000,000 | 241,000,000 | 188,000,000 | 135,087,000 | 115,260,000 | 106,747,000 | 110,000,000 | 121,936,000 | 112,288,000 | 105,188,000 | 94,252,000 | 74,972,000 | 75,408,000 |
R&D Expenses | 11.3% | 4,310,000,000 | 3,872,000,000 | 3,295,000,000 | 2,732,000,000 | 2,433,000,000 | 2,144,000,000 | 1,991,000,000 | 2,102,000,000 | 1,925,000,000 | 1,656,000,000 | 1,370,000,000 | 728,645,000 | 504,282,000 | 480,587,000 | 496,000,000 | 528,784,000 | 518,197,000 | 494,371,000 | 454,082,000 | 404,870,667 | 389,206,000 |
EBITDA | -100.0% | - | 5,413,000,000 | 9,948,000,000 | - | 15,968,000,000 | 16,564,000,000 | 13,531,000,000 | - | - | 687,063,000 | -704,472,000 | -563,923,000 | -456,516,000 | -475,315,000 | -484,000,000 | -500,148,000 | -457,886,000 | -414,665,000 | - | - | - |
EBITDA Margin | -100.0% | - | 0.36 | 0.52 | - | 0.69 | 0.73 | 0.73 | - | - | 0.25 | -0.88 | -2.29 | -4.31 | -9.04 | -8.04 | -6.13 | -4.31 | -3.40 | - | - | - |
Interest Expenses | - | - | - | 25,000,000 | - | - | - | 14,000,000 | - | - | - | 9,000,000 | - | - | - | 6,000,000 | - | - | - | 2,998,000 | - | - |
Earnings Before Taxes | -83.8% | 818,000,000 | 5,041,000,000 | 9,575,000,000 | 13,330,000,000 | 15,665,000,000 | 16,254,000,000 | 13,285,000,000 | 7,604,000,000 | 3,820,000,000 | 640,000,000 | -744,000,000 | -596,743,000 | -488,136,000 | -506,400,000 | -515,000,000 | -532,515,000 | -489,453,000 | -444,632,000 | -384,408,000 | -324,200,000 | -325,638,000 |
EBT Margin | -100.0% | - | 0.33 | 0.50 | 0.62 | 0.68 | 0.72 | 0.72 | 0.64 | 0.54 | 0.23 | -0.93 | -2.42 | -4.61 | -9.64 | -8.55 | - | - | - | - | - | - |
Net Income | -74.8% | 1,207,000,000 | 4,784,000,000 | 8,362,000,000 | 11,765,000,000 | 14,055,000,000 | 14,638,000,000 | 12,202,000,000 | 7,061,000,000 | 3,495,000,000 | 598,000,000 | -747,000,000 | -597,269,000 | -487,484,000 | -505,424,000 | -514,000,000 | -532,157,000 | -489,273,000 | -444,934,000 | -384,734,000 | -324,410,666 | -325,954,000 |
Net Income Margin | -100.0% | - | 0.32 | 0.43 | 0.55 | 0.61 | 0.65 | 0.66 | 0.60 | 0.50 | 0.22 | -0.93 | -2.42 | -4.61 | -9.62 | -8.54 | - | - | - | - | - | - |
Free Cashflow | -100.0% | - | 612,000,000 | 4,581,000,000 | 6,201,000,000 | 9,215,000,000 | 13,031,000,000 | 13,336,000,000 | 11,386,436,000 | 9,083,037,000 | 5,007,746,000 | 1,959,523,000 | 613,169,000 | -371,194,000 | -451,223,000 | -490,522,000 | - | - | - | - | - | - |
Balance Sheet | (In Millions) | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2017Q4 |
Assets | -9.3% | 21,884 | 24,125 | 25,858 | 26,056 | 26,043 | 27,609 | 24,669 | 20,923 | 16,153 | 12,694 | 7,337 | 4,651 | 3,486 | 2,068 | 1,589 | 1,591 | 1,685 | 1,806 | 1,962 | 1,084 |
Current Assets | -12.6% | 10,599 | 12,122 | 13,431 | 14,297 | 13,563 | 16,350 | 16,071 | 13,425 | 10,969 | 11,703 | 6,298 | 3,577 | 2,797 | 1,250 | 1,129 | 1,094 | 1,097 | 1,141 | 1,563 | 783 |
Cash Equivalents | 10.5% | 3,801 | 3,441 | 3,205 | 3,027 | 2,873 | 5,048 | 6,860 | 5,550 | 5,603 | 5,442 | 2,624 | 1,506 | 1,762 | 392 | 248 | 174 | 152 | 503 | 670 | 148 |
Inventory | -2.3% | 715 | 732 | 949 | 2,077 | 1,921 | 1,942 | 1,441 | 965 | 643 | 494 | 47.00 | - | - | - | - | - | - | - | - | - |
Net PPE | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 204 | 209 | 213 | 212 | 139 |
Liabilities | -6.2% | 4,935 | 5,262 | 6,735 | 8,064 | 8,058 | 10,534 | 10,524 | 10,799 | 9,449 | 8,856 | 4,776 | 1,891 | 539 | 427 | 415 | 339 | 347 | 360 | 432 | 459 |
Current Liabilities | -10.7% | 3,123 | 3,499 | 4,923 | 6,807 | 6,812 | 9,238 | 9,128 | 9,957 | 8,840 | 8,441 | 4,389 | 1,474 | 162 | 135 | 143 | 148 | 162 | 159 | 223 | 191 |
Shareholder's Equity | -10.1% | 16,949 | 18,863 | 19,123 | 17,992 | 17,985 | 17,075 | 14,145 | 10,124 | 6,704 | 3,838 | 2,561 | 2,760 | 2,947 | 1,641 | 1,175 | 1,248 | 1,335 | 1,442 | 1,530 | - |
Retained Earnings | -7.5% | 17,019 | 18,399 | 18,320 | 16,855 | 15,812 | 13,615 | 9,958 | 5,090 | 1,757 | -1,023 | -2,244 | -1,970 | -1,740 | -1,620 | -1,496 | -1,369 | -1,246 | -1,111 | -982 | -621 |
Additional Paid-In Capital | -73.6% | 193 | 731 | 1,173 | 1,488 | 2,413 | 3,644 | 4,211 | 5,003 | 4,931 | 4,860 | 4,802 | 4,726 | 4,676 | 3,268 | 2,669 | 2,618 | 2,582 | 2,557 | 2,538 | 72.00 |
Shares Outstanding | -0.8% | 381 | 384 | 385 | 387 | 396 | 402 | 403 | 404 | 402 | 400 | 399 | 395 | 381 | 353 | 337 | 331 | 329 | 329 | 81.00 | 64.00 |
Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Cashflow From Operations | -122.8% | -226 | 993 | 4,981 | 6,629 | 9,653 | 13,412 | 13,620 | 11,574 | 9,191 | 5,104 | 2,027 | 664 | -336 | -420 | -459 | -450 | -424 | -363 | -330 | -319 | -319 |
Share Based Compensation | 9.3% | 281 | 257 | 226 | 201 | 171 | 156 | 142 | 131 | 113 | 103 | 93.00 | 87.00 | 86.00 | 83.00 | 81.00 | 92.00 | 86.00 | 79.00 | 73.00 | 55.00 | 52.00 |
Cashflow From Investing | 409.5% | 3,852 | 756 | -5,176 | -5,266 | -9,538 | -12,264 | -8,523 | -7,575 | -5,427 | -1,536 | -1,672 | -1,351 | -59.34 | -319 | -15.00 | -139 | -136 | 99.00 | -373 | -505 | -990 |
Cashflow From Financing | 19.7% | -2,689 | -3,348 | -3,448 | -3,883 | -2,844 | -1,541 | -873 | 44.00 | 76.00 | 1,481 | 2,033 | 2,021 | 2,007 | 630 | 52.00 | 596 | 571 | 677 | 1,227 | 868 | 1,321 |
Buy Backs | -20.7% | 2,562 | 3,232 | 3,329 | 3,784 | 2,778 | 1,480 | 857 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Revenue: | ||||
Total revenue | $ 344 | $ 4,749 | $ 2,206 | $ 10,815 |
Operating expenses: | ||||
Cost of sales | 731 | 1,381 | 1,523 | 2,398 |
Research and development | 1,148 | 710 | 2,279 | 1,264 |
Selling, general and administrative | 332 | 211 | 637 | 479 |
Total operating expenses | 2,211 | 2,302 | 4,439 | 4,141 |
(Loss) income from operations | (1,867) | 2,447 | (2,233) | 6,674 |
Interest income | 104 | 40 | 213 | 55 |
Other income (expense), net | 14 | (13) | (34) | (26) |
(Loss) income before income taxes | (1,749) | 2,474 | (2,054) | 6,703 |
(Benefit from) provision for income taxes | (369) | 277 | (753) | 849 |
Net (loss) income | $ (1,380) | $ 2,197 | $ (1,301) | $ 5,854 |
(Loss) earnings per share: | ||||
Basic (in usd per share) | $ (3.62) | $ 5.55 | $ (3.39) | $ 14.66 |
Diluted (in usd per share) | $ (3.62) | $ 5.24 | $ (3.39) | $ 13.85 |
Weighted average common shares used in calculation of (loss) earnings per share: | ||||
Basic (in shares) | 381 | 396 | 383 | 399 |
Diluted (in shares) | 381 | 419 | 383 | 423 |
Product sales | ||||
Revenue: | ||||
Total revenue | $ 293 | $ 4,531 | $ 2,121 | $ 10,456 |
Other revenue | ||||
Revenue: | ||||
Total revenue | $ 51 | $ 218 | $ 85 | $ 359 |
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions | Jun. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 3,801 | $ 3,205 |
Investments | 4,658 | 6,697 |
Accounts receivable | 232 | 1,385 |
Inventory | 715 | 949 |
Prepaid expenses and other current assets | 1,193 | 1,195 |
Total current assets | 10,599 | 13,431 |
Investments, non-current | 6,105 | 8,318 |
Property, plant and equipment, net | 2,280 | 2,018 |
Right-of-use assets, operating leases | 130 | 121 |
Deferred tax assets | 1,480 | 982 |
Other non-current assets | 1,290 | 988 |
Total assets | 21,884 | 25,858 |
Current liabilities: | ||
Accounts payable | 310 | 487 |
Accrued liabilities | 1,490 | 2,101 |
Deferred revenue | 1,040 | 2,038 |
Income taxes payable | 47 | 48 |
Other current liabilities | 236 | 249 |
Total current liabilities | 3,123 | 4,923 |
Deferred revenue, non-current | 692 | 673 |
Operating lease liabilities, non-current | 104 | 92 |
Financing lease liabilities, non-current | 843 | 912 |
Other non-current liabilities | 173 | 135 |
Total liabilities | 4,935 | 6,735 |
Commitments and contingencies (Note 13) | ||
Stockholders’ equity: | ||
Preferred stock, par value $0.0001; 162 shares authorized as of June 30, 2023 and December 31, 2022; no shares issued or outstanding at June 30, 2023 and December 31, 2022 | 0 | 0 |
Common stock, par value $0.0001; 1,600 shares authorized as of June 30, 2023 and December 31, 2022; 381 and 385 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively | 0 | 0 |
Additional paid-in capital | 193 | 1,173 |
Accumulated other comprehensive loss | (263) | (370) |
Retained earnings | 17,019 | 18,320 |
Total stockholders’ equity | 16,949 | 19,123 |
Total liabilities and stockholders’ equity | $ 21,884 | $ 25,858 |